Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:07 AM
Ignite Modification Date:
2025-12-25 @ 2:07 AM
NCT ID:
NCT01993160
Eligibility Criteria:
Inclusion Criteria:
* Age ≥ 18 years
* Histologic diagnosis of carcinoma of prostate
* High risk disease: defined as Gleason ≥8, or T3 disease, or PSA \>20ng/mL
* No prior therapy for prostate cancer (surgery, radiation therapy, hormone therapy, chemotherapy).
* Ability to provide written informed consent to participate in the study
Exclusion Criteria:
* Prior surgery or radiation therapy for prostate cancer
* Prior or ongoing hormone or other systemic therapy for prostate cancer
* Inability to lie supine for 90 minutes
* Any contraindication to MR as per Joint Department of Medical Imaging policies.
* Impaired kidney function with glomerular filtration rate \< 30ml/min
* Previous anaphylactic reaction to gadolinium or other contraindications to MR.
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
18 Years
Maximum Age:
99 Years
Study:
NCT01993160
Study Brief:
Protocol Section:
NCT01993160